Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call shows a strong financial performance with revenue, net income, and EPS growth, but the market environment is volatile, and there are regulatory and supply chain challenges. The Q&A highlights uncertainties in guidance and restructuring details, impacting investor sentiment. The dividend payment supports shareholder value, but the overall mixed signals lead to a neutral outlook for stock price movement.
Revenue $181,900,000 (5.9% increase year-over-year) - Driven by broad-based contributions with five practices growing year-over-year, including four practices (energy, finance, intellectual property, and life sciences) posting double-digit revenue growth.
Non GAAP Net Income Increased by 11% year-over-year - Reflects effective management and conversion of top-line growth into bottom-line expansion.
Earnings per Diluted Share Increased by 13% year-over-year - Indicates strong profitability and operational efficiency.
EBITDA Increased by 11% year-over-year - Consistent with the overall strong performance and effective management of the business.
Consultant Headcount Decreased by 5% year-over-year to 947 - Reflects optimization efforts in response to revenue opportunities.
Consulting Utilization Improved to 76% year-over-year - Supported by the replenishing of the sales pipeline and increased project lead flow.
Non GAAP Selling, General and Administrative Expenses 15.9% of revenue (compared to 15.6% year-over-year) - Slight increase attributed to the costs associated with maintaining operational efficiency.
Effective Tax Rate (Non GAAP) 27.2% (compared to 28% year-over-year) - A decrease indicating improved tax efficiency.
Days Sales Outstanding (DSO) 107 days (compared to 106 days at the end of Q4 FY24) - Indicates stable collection period for receivables.
Cash $25,600,000 - Reflects the company's liquidity position.
Borrowings under Revolving Credit Facility $85,000,000 - Primarily used to fund bonus payments, consistent with prior years.
Net Debt $59,400,000 - Indicates the company's leverage position.
Cash Outlays for Talent Acquisition and Retention $27,400,000 - Reflects investment in senior talent to support growth.
Capital Expenditures $1,000,000 - Represents investment in infrastructure.
Dividends Delivered to Shareholders $3,500,000 - Indicates commitment to returning value to shareholders.
Revenue Growth in Legal and Regulatory Services: Revenue in the first quarter from CRA’s legal and regulatory services increased by roughly 5%.
M&A Market Activity: Worldwide M&A activity reached $885 billion during the first quarter of 2025, representing a 15% increase compared to year ago levels.
International Operations Growth: CRA’s international operations led the way with nearly 20% year over year revenue growth.
Life Sciences Practice Growth: CRA’s life sciences practice emphasized R&D pipeline opportunities, focusing on opportunity assessment, sales forecasting, and launch planning.
Consultant Headcount: Consultant headcount decreased by 5% year over year, ending the quarter at 947.
Consulting Utilization Rate: Consulting utilization improved year over year to 76%.
Project Lead Flow: Project lead flow increased by 5% year over year.
Restructuring Charge: Restructuring efforts affected approximately 15 individuals, resulting in a charge offset by the reversal of non-cash charges.
Full Year Financial Guidance: CRA reaffirmed its full year financial guidance for fiscal 2025, expecting revenue in the range of $715 million to $725 million.
Optimizing Service Portfolio: CRA continues to look for opportunities to optimize its service portfolio by reconfiguring teams in targeted areas.
Economic Conditions: Uncertain global macroeconomic, business, and political conditions can be volatile and affect CRA's business.
Consultant Headcount: Consultant headcount decreased by 5% year over year, indicating potential challenges in talent retention and resource allocation.
Restructuring Charges: A restructuring charge affected approximately 15 individuals, suggesting challenges in optimizing team configurations and aligning resources with revenue opportunities.
Competitive Pressures: The company faces competitive pressures in the antitrust and competition economics practice, which is experiencing high demand but also significant scrutiny from regulatory bodies.
Market Volatility: The market environment has been described as choppy, with fluctuations in business inflow and project originations, indicating potential risks in maintaining consistent revenue growth.
Regulatory Issues: Ongoing antitrust investigations and regulatory scrutiny in the tech sector may pose risks to client engagements and overall market stability.
Supply Chain Challenges: The company is involved in projects related to supply chain issues, such as the impacts of California wildfires on infrastructure investments, highlighting external risks.
Revenue Growth: Revenue increased by 5.9% year over year to $181,900,000, the highest quarterly revenue in the company’s history.
Consulting Utilization: Consulting utilization improved year over year to 76%.
Project Lead Flow: Project lead flow accelerated during the quarter, increasing by 5% year over year.
Restructuring: Approximately 15 individuals were affected by restructuring efforts to optimize service portfolio.
Cross-Practice Collaboration: Collaboration across practices and geographies is emphasized to deliver the best services to clients.
Full Year Revenue Guidance: For fiscal 2025, revenue is expected to be in the range of $715,000,000 to $725,000,000.
Non-GAAP EBITDA Margin Guidance: Non-GAAP EBITDA margin is expected to be in the range of 12% to 13%.
Market Conditions: Management is mindful of uncertain global macroeconomic, business, and political conditions that may affect business.
Dividends Paid: $3,500,000 delivered to shareholders during the first quarter.
The earnings call summary and Q&A indicate strong financial performance, optimistic guidance, and strategic growth in key areas like energy and life sciences. The increase in dividends and share repurchases is a positive indicator for shareholder returns. Although there are concerns about headcount and long-term visibility, these are outweighed by positive growth metrics and strategic positioning. Given the market cap of $1.2 billion, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.
The earnings call shows a strong financial performance with revenue, net income, and EPS growth, but the market environment is volatile, and there are regulatory and supply chain challenges. The Q&A highlights uncertainties in guidance and restructuring details, impacting investor sentiment. The dividend payment supports shareholder value, but the overall mixed signals lead to a neutral outlook for stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.